Tag: biosimilars
Global Biosimilar Markets: Europe vs United States
Posted by Elias Kellerman in Medications
28Feb
Europe led the world in biosimilar adoption with a clear regulatory system, while the US struggled with patents and complex rules. Now, thanks to FDA changes and the Inflation Reduction Act, the US market is accelerating fast - with biosimilars poised to cut costs for millions.
MoreAddressing Patient Concerns About Biosimilars: Reducing Hesitation and Building Trust
Posted by Elias Kellerman in Medications
24Jan
Biosimilars offer major cost savings but face patient hesitation due to confusion with generics and lack of transparency. Learn how to build trust, understand safety, and ensure real savings.
MoreBiologic Drugs: Why They Can't Be Copied Like Regular Pills
Posted by Elias Kellerman in Medications
19Dec
Biologic drugs are made from living cells, not chemicals, so they can't be copied like regular pills. Biosimilars offer similar benefits but aren't exact copies-and that's by design.
More